The estimated Net Worth of David Francis O'brien is at least $356 millier dollars as of 25 August 2020. Mr brien owns over 5,746 units of SINTX Technologies Inc stock worth over $18,904 and over the last 4 years he sold SINT stock worth over $0. In addition, he makes $337,230 as Chief Operating Officer at SINTX Technologies Inc.
Mr has made over 1 trades of the SINTX Technologies Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he bought 5,746 units of SINT stock worth $9,998 on 25 August 2020.
The largest trade he's ever made was buying 5,746 units of SINTX Technologies Inc stock on 25 August 2020 worth over $9,998. On average, Mr trades about 5,746 units every 0 days since 2020. As of 25 August 2020 he still owns at least 5,746 units of SINTX Technologies Inc stock.
You can see the complete history of Mr brien stock trades at the bottom of the page.
David Francis O'Brien is the Chief Operating Officer at SINTX Technologies Inc.
As the Chief Operating Officer of SINTX Technologies Inc, the total compensation of Mr Brien at SINTX Technologies Inc is $337,230. There are 2 executives at SINTX Technologies Inc getting paid more, with Dr. B. Sonny Bal J.D., M.D., MBA, Ph.D. having the highest compensation of $483,044.
Mr Brien is 56, he's been the Chief Operating Officer of SINTX Technologies Inc since . There are 7 older and 3 younger executives at SINTX Technologies Inc. The oldest executive at SINTX Technologies Inc is Dr. Bryan J. McEntire MBA, Ph.D., 69, who is the Chief Scientific Officer.
David's mailing address filed with the SEC is 2100 South, Salt Lake City, Salt Lake County, Utah, 84199, United States of America.
Over the last 4 years, insiders at SINTX Technologies Inc have traded over $8 worth of SINTX Technologies Inc stock and bought 5,746 units worth $9,998 . The most active insiders traders include David W. Truetzel et David Francis O'brien. On average, SINTX Technologies Inc executives and independent directors trade stock every 413 days with the average trade being worth of $9,564. The most recent stock trade was executed by David W. Truetzel on 29 November 2022, trading 67 units of SINT stock currently worth $8.
amedica is the only manufacturer of medical grade silicon nitride, an innovative biomaterial technology ideal for use in spinal fusion and across a variety of medical applications. our silicon nitride features a unique nanosurface texture that promotes bone growth and addresses clinical needs by providing excellent imaging capabilities and demonstrating antibacterial characteristics. our interbody fusion devices and pedicle screw systems are designed to benefit both the patient and the surgeon. with the only fda registered and iso 1345 certified silicon nitride medical device manufacturing facility in the world and a strong sales and distribution organization, we are committed to providing innovative healthcare solutions that improve patient quality of life.
SINTX Technologies Inc executives and other stock owners filed with the SEC include: